Alternative splicing, or alternative RNA splicing, or differential splicing, is an alternative splicing process during gene expression that allows a single gene to code for multiple proteins.
FactSnippet No. 1,096,801 |
Alternative splicing, or alternative RNA splicing, or differential splicing, is an alternative splicing process during gene expression that allows a single gene to code for multiple proteins.
FactSnippet No. 1,096,801 |
Biologically relevant alternative splicing occurs as a normal phenomenon in eukaryotes, where it increases the number of proteins that can be encoded by the genome.
FactSnippet No. 1,096,802 |
Mechanisms of alternative splicing are highly variable, and new examples are constantly being found, particularly through the use of high-throughput techniques.
FactSnippet No. 1,096,803 |
Abnormal variations in Alternative splicing are implicated in disease; a large proportion of human genetic disorders result from Alternative splicing variants.
FactSnippet No. 1,096,804 |
Abnormal Alternative splicing variants are thought to contribute to the development of cancer, and Alternative splicing factor genes are frequently mutated in different types of cancer.
FactSnippet No. 1,096,805 |
In 2021, it was discovered that the genome of adenovirus type 2, the adenovirus in which alternative splicing was first identified, was able to produce a much greater variety of mRNA than previously thought.
FactSnippet No. 1,096,806 |
The majority of Alternative splicing repressors are heterogeneous nuclear ribonucleoproteins such as hnRNPA1 and polypyrimidine tract binding protein .
FactSnippet No. 1,096,807 |
Genuine alternative splicing occurs in both protein-coding genes and non-coding genes to produce multiple products .
FactSnippet No. 1,096,808 |
Comparative studies indicate that alternative splicing preceded multicellularity in evolution, and suggest that this mechanism might have been co-opted to assist in the development of multicellular organisms.
FactSnippet No. 1,096,809 |
One study found that a relatively small percentage of alternative splicing variants were significantly higher in frequency in tumor cells than normal cells, suggesting that there is a limited set of genes which, when mis-spliced, contribute to tumor development.
FactSnippet No. 1,096,810 |
One example of a specific Alternative splicing variant associated with cancers is in one of the human DNMT genes.
FactSnippet No. 1,096,811 |
High-throughput approaches to investigate Alternative splicing have been developed, such as: DNA microarray-based analyses, RNA-binding assays, and deep sequencing.
FactSnippet No. 1,096,812 |
When combined with Alternative splicing assays, including in vivo reporter gene assays, the functional effects of polymorphisms or mutations on the Alternative splicing of pre-mRNA transcripts can then be analyzed.
FactSnippet No. 1,096,813 |
Use of reporter assays makes it possible to find the splicing proteins involved in a specific alternative splicing event by constructing reporter genes that will express one of two different fluorescent proteins depending on the splicing reaction that occurs.
FactSnippet No. 1,096,814 |